Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Valbiotis SA (8JD.F)

Compare
1.2480
-0.0280
(-2.19%)
At close: February 21 at 8:16:31 AM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
527
4,733
785
298
3,092
Cost of Revenue
3,045
2,065
18
16
4
Gross Profit
-2,518
2,668
767
282
3,088
Operating Expense
6,550
9,846
12,792
8,758
6,458
Operating Income
-9,068
-7,178
-12,025
-8,476
-3,370
Net Non Operating Interest Income Expense
118
-188
-288
-206
-421
Pretax Income
-8,951
-7,368
-12,314
-8,681
-3,829
Tax Provision
-7
--
-2
--
--
Net Income Common Stockholders
-8,944
-7,368
-12,312
-8,681
-3,829
Diluted NI Available to Com Stockholders
-8,944
-7,368
-12,312
-8,681
-3,829
Basic EPS
-0.65
-0.59
-1.21
-0.94
-0.52
Diluted EPS
-0.65
-0.59
-1.21
-0.94
-0.52
Basic Average Shares
14,146.8260
12,461.9870
10,114.7120
9,157.8400
7,452.9030
Diluted Average Shares
15,763.3000
12,461.9870
10,114.7120
9,157.8400
7,452.9030
Total Operating Income as Reported
-8,756
-7,180
-12,026
-8,475
-3,407
Total Expenses
9,595
11,911
12,810
8,774
6,462
Net Income from Continuing & Discontinued Operation
-8,944
-7,368
-12,312
-8,681
-3,829
Normalized Income
-8,944
-7,368
-12,312
-8,681
-3,794
Interest Income
-111
--
1
142
--
Interest Expense
132
221
227
229
421
Net Interest Income
118
-188
-288
-206
-421
EBIT
-8,819
-7,147
-12,087
-8,452
-3,408
EBITDA
-7,269
-6,411
-11,235
-7,511
-2,371
Reconciled Cost of Revenue
3,045
2,065
18
16
4
Reconciled Depreciation
1,550
736
852
941
1,037
Net Income from Continuing Operation Net Minority Interest
-8,944
-7,368
-12,312
-8,681
-3,829
Total Unusual Items Excluding Goodwill
--
--
--
--
-35
Total Unusual Items
--
--
--
--
-35
Normalized EBITDA
-7,269
-6,411
-11,235
-7,511
-2,336
Tax Rate for Calcs
0
--
0
--
--
12/31/2020 - 2/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRO.F hVIVO plc
0.1870
0.00%
 
PHPN.F Galectin Therapeutics Inc.
1.3700
+0.74%
 
2X10.F ABIVAX Société Anonyme
6.85
+1.48%
 
6XY.F HBM Holdings Limited
0.6450
+4.03%
 
HPHA.F Heidelberg Pharma AG
2.3100
-0.43%
 
J90.F NurExone Biologic Inc.
0.4260
+8.67%
 
ALTME.PA TME Pharma N.V.
0.0731
-2.14%
 
SEOVF Sernova Biotherapeutics Inc
0.1400
-1.41%
 
HVO.L hVIVO plc
17.75
-0.28%
 
NBTX Nanobiotix S.A.
3.7500
-1.57%